Lincoln Pharmaceuticals launches long-acting paracetamol

Lincoln Pharmaceuticals Limited (LPL) has announced a new drug delivery system for paracetamol that allows a patient to get long hours of relief compared to conventional paracetamol tablets.

Ahmedabad-based Lincoln pharmaceuticals last week announced the launch of a long-acting Paracetamol, Pa-12, which the company claimed to be the first in India.

Long-acting pain medications stay in the system for an extended period of time, giving longer-time relief from fever and pain.

Paracetamol is the time-tested molecule that controls fever and pain. In comparison to conventional oral paracetamol tablets, clinical trials have proved that Pa-12 is more effective with longer acting action and fewer side effects.

Pa-12 contains 1,000mg paracetamol, programmed for "non-stop 12 hours fever control with 1 tab only". In a day a patient will need only two tablets of Pa-12 instead of 3 to 4 tablets of conventional oral paracetamol tablets, the company said in a release.

Lincoln Pharamaceuticals has applied for patent for this novel drug delivery system. The new launch will strengthen the company's position in the pharmaceutical industry.